MCDONOUGH JOHN (President & CEO) sold 3.4% of their position (18.18K shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $21.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/2/2021ACC: 0000899243-21-027184
DirectorOfficer· President & CEO
Since Jul 2018
-18.18K
Net shares
Net seller
$21.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
18.18K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−18.18K
Price / share
$1.16
Trade value
$21.09K
% of position
3.4%
7/1/2021
534.57K→516.39K
Total
Net shares
−18.18K
Net value
-$21.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2021 | S · Sale | −18.18K | $1.16 | $21.09K | 3.4% | 534.57K | 516.39K |
| Total | −18.18K | -$21.09K | ||||||
Derivative Transactions0
No derivative transactions reported